Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Galenfeha, Inc. (GLFH) Benefitting from Increased Demand for Stored Energy Solutions following the Release of Tesla (TSLA) Energy

While Tesla Motors, Inc. (TSLA) continues to make headlines with the rapid growth and development of its new battery grid business – with recent estimates forecasting $45 million in sales during the fourth quarter of this year – the resulting rise in demand for reliable battery systems is providing a platform for strong financial growth […]

Arotech Corp. (ARTX) Announces $6.7 Million Production Contract

Earlier today, Arotech reported a $6.7 task order from the Space and Naval Warfare Center (SPAWAR) Atlantic. The contract came through its North American Power System Division, which includes UEC Electronics. The contract awarded is for the manufacture and integration of 12 Communication Emitter Sensing and Attacking System (CESAS) II Platform Integration Kits (PIK). The […]

ENGlobal Corp. (ENG) Given Positive Writeup in Seeking Alpha

ENGlobal Corp., a specialty engineering services firm that focuses on oil and gas automation solutions, subsea control systems, and engineering and construction projects, was recently highlighted in a Seeking Alpha article, touching on how the company’s management team has turned the company back to profitability and staying profitable in spite of the current energy slump. […]

Alternet Systems Inc. (ALYI) and the Future of Money

Alternet has a history of recognizing and investing in technologies of the future. As technology has progressed, the company has widened its search for investment and partnership opportunities from internet phone service, e-tickets and mobile payments to digital banking and currency. Alternet has a vision of a world where people have access to well-organized and […]

GrowBLOX Sciences, Inc. (GBLX) Cultivation Technology Promises to Deliver Pure, High-Value Strains at Scalable Production Volumes

Medical marijuana continues to act as the narrow end of the wedge for a broader legalization of cannabis and cannabis-derived products nationwide, with parents now demanding medical access across the country to what they see as relatively-safe, life-saving drugs. Such as in the cases like those of two young girls in Pittsburgh (where legislation is […]

Star Mountain Resources Inc. (SMRS) Pursues Acquisition Opportunities in North American Mining Sector

Star Mountain Resources, a minerals exploration company focused on acquiring and consolidating mining claims, mineral leases, producing mines, and historic mines with production and future growth potential identified through exploration efforts, announced it is continually pursuing merger and acquisition opportunities for mines, advanced projects and immature projects that are available at opportunistic costs as a […]

International Stem Cell Corp. (ISCO) Posts Record Financial Results in the Second Quarter of 2015

International Stem Cell Corp. is expanding its presence in the emerging field of regenerative medicine through the development of its novel stem cell-based therapies and biomedical products. In recent months, this progress has translated into record-setting financial results, as the company has continued to position itself as a major player in the biotechnology industry. “Stable […]

 

From Our Blog

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibitor, Poised to Improve Cancer Treatment Outcomes

March 31, 2026

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100. The LB-100 compound is a proprietary small-molecule PP2A inhibitor that is designed to target protein phosphatase 2A (“PP2A”), introducing a potential new treatment paradigm aimed at enhancing existing […]

Rotate your device 90° to view site.